First-trimester screening in pregnancies conceived by assisted reproductive technology: Significance of gestational dating by oocyte retrieval or sonographic measurement of crown-rump length

Ultrasound in Obstetrics and Gynecology

Volumn 32, Issue 5, 2008, Pages 612-617

  Gjerris, A C ^a   Loft, A ^a   Pinborg, A ^a   Tabor, A ^a   Christiansen, M ^b  

^a Rigshospitalet   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

ART; Combined screening; First trimester; Free hCG; Gestational age; Nuchal translucency; PAPP A

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; BLOOD SAMPLING; CHROMOSOME ABERRATION; CROWN RUMP LENGTH; FEMALE; FERTILIZATION IN VITRO; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; FOLLICULAR ASPIRATION; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MATERNAL BLOOD; NUCHAL TRANSLUCENCY MEASUREMENT; OOCYTE RETRIEVAL; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; BODY WEIGHT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOME DISORDERS; COHORT STUDIES; CROWN-RUMP LENGTH; FEMALE; GESTATIONAL AGE; HUMANS; OOCYTE RETRIEVAL; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROSPECTIVE STUDIES; REPRODUCTIVE TECHNIQUES, ASSISTED; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 55549083896     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.6128     Document Type: Article

References (33)

1. Campbell S, Warsof SL, Little D, Cooper DJ. Routine ultrasound screening for the prediction of gestational age. Obstet Gynecol 1985; 65: 613-620.
2. Savitz DA, Terry JW, Jr, Dole N, Thorp JM, Jr, Siega-Riz AM, Herring AH. Comparison of pregnancy dating by last menstrual period, ultrasound scanning, and their combination. Am J Obstet Gynecol 2002; 187: 1660-1666.
3. Tunon K, Eik-Nes SH, Grottum P. A comparison between ultrasound and a reliable last menstrual period as predictors of the day of delivery in 15,000 examinations. Ultrasound Obstet Gynecol 1996; 8: 178-185.
4. Grinsted J, Avery B. A sporadic case of delayed implantation after in-vitro fertilization in the human? Hum Reprod 1996; 11: 651-654.
5. Naaktgeboren N, Devroey P, Wisanto A, Traey E, Van Steirteghem AC. Endocrine profiles in early pregnancies with delayed implantation. Hum Reprod 1986; 1: 9-14.
6. Ahlborg L, Ek S, Fridstrom M, Kublickas M, Leijon M, Nisell H. Is fetal growth impaired after in vitro fertilization? Acta Obstet Gynecol Scand 2006; 85: 195-199.
7. Sladkevicius P, Saltvedt S, Almstrom H, Kublickas M, Grunewald C, Valentin L. Ultrasound dating at 12-14 weeks of gestation. A prospective cross-validation of established dating formulae in in-vitro fertilized pregnancies. Ultrasound Obstet Gynecol 2005; 26: 504-511.
8. Tunón K, Eik-Nes SH, Grottum P, Von Düring V, Kahn JA. Gestational age in pregnancies conceived after in vitro fertilization: a comparison between age assessed from oocyte retrieval, crown-rump length and biparietal diameter. Ultrasound Obstet Gynecol 2000; 15: 41-46.
9. Wennerholm UB, Bergh C, Hagberg H, Sultan B, Wennergren M. Gestational age in pregnancies after in vitro fertilization: comparison between ultrasound measurement and actual age. Ultrasound Obstet Gynecol 1998; 12: 170-174.
10. Grange G, Pannier E, Goffinet F, Cabrol D, Zorn JR. Dating biometry during the first trimester: accuracy of an every-day practice. Eur J Obstet Gynecol Reprod Biol 2000; 88: 61-64.
11. Saltvedt S, Almstrom H, Kublickas M, Reilly M, Valentin L, Grunewald C. Ultrasound dating at 12-14 or 15-20 weeks of gestation? A prospective cross-validation of established dating formulae in a population of in-vitro fertilized pregnancies randomized to early or late dating scan. Ultrasound Obstet Gynecol 2004; 24: 42-50.
12. Ghisoni L, Ferrazzi E, Castagna C, Levi Setti PE, Masini AC, Pigni A. Prenatal diagnosis after ART success: the role of early combined screening tests in counselling pregnant patients. Placenta 2003; 24 (Suppl B): S99-S103.
13. Liao AW, Heath V, Kametas N, Spencer K, Nicolaides KH. First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 2001; 16: 1501-1504.
14. Orlandi F, Rossi C, Allegra A, Krantz D, Hallahan T, Orlandi E, Macri J. First trimester screening with free beta-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn 2002; 22: 718-721.
15. Tul N, Novak-Antolic Z. Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception. Prenat Diagn 2006; 26: 1206-1211.
16. Bellver J, Lara C, Soares SR, Ramírez A, Pellicer A, Remohí J, Serra V. First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction. Hum Reprod 2005; 20: 2623-2627.
17. Wøjdemann KR, Larsen SO, Shalmi A, Sundberg K, Christiansen M, Tabor A. First trimester screening for Down syndrome and assisted reproduction: no basis for concern. Prenat Diagn 2001; 21: 563-565.
18. Hui PW, Tang MH, Lam YH, Yeung WS, Ng EH, Ho PC. Nuchal translucency in pregnancies conceived after assisted reproduction technology. Ultrasound Obstet Gynecol 2005; 25: 234-238.
19. Maymon R, Shulman A. Serial first- and second-trimester Down's syndrome screening tests among IVF-versus naturally-conceived singletons. Hum Reprod 2002; 17: 1081-1085.
20. Robinson HP, Fleming JE. A critical evaluation of sonar "crown-rump length" measurements. Br J Obstet Gynaecol 1975; 82: 702-710.
21. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352: 343-346.
22. Larsen SO, Christiansen M, Norgaard-Pedersen B. Calculation of roc curves in multidimensional likelihood ratio based screening with Down's syndrome as a special case. J Med Screen 1998; 5: 57-62.
23. Cuckle HS, van Lith JM. Appropriate biochemical parameters in first-trimester screening for Down syndrome. Prenat Diagn 1999; 19: 505-512.
24. van der Veen WJ, Beekhuis JR, Cornel MC, Mantingh A, de Walle HE, de Wolf BT. A demographic approach to the assessment of Down syndrome screening performance. Prenat Diagn 1997; 17: 717-724.
25. Hecht CA, Hook EB. Rates of Down syndrome at livebirth by one-year maternal age intervals in studies with apparent close to complete ascertainment in populations of European origin: a proposed revised rate schedule for use in genetic and prenatal screening. Am J Med Genet 1996; 62: 376-385.
26. th edn). Lippincott Williams & Wilkins: Baltimore, 2004.
27. Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Reprod Biomed Online 2007; 14: 640-649.
28. Andersen AN, Devroey P, Arce JC. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod 2006; 21: 3217-3227.
29. Wisser J, Dirschedl P, Krone S. Estimation of gestational age by transvaginal sonographic measurement of greatest embryonic length in dated human embryos. Ultrasound Obstet Gynecol 1994; 4: 457-462.
30. Eik-Nes SH, Grottum P, Jorgensen NP, Løkvik B. Normal Range Curves for BPD and MAD. Scan-Med a/s: Drammen, Norway, 1983.
31. Persson PH, Weldner BM. Reliability of ultrasound fetometry in estimating gestational age in the second trimester. Acta Obstet Gynecol Scand 1986; 65: 481-483.
32. Hui PW, Lam YH, Tang MH, Ng EH, Yeung WS, Ho PC. Maternal serum pregnancy-associated plasma protein-A and free beta-human chorionic gonadotropin in pregnancies conceived with fresh and frozen-thawed embryos from in vitro fertilization and intracytoplasmic sperm injection. Prenat Diagn 2005; 25: 390-393.
33. Weisz B, Rodeck CH. An update on antenatal screening for Down's syndrome and specific implications for assisted reproduction pregnancies. Hum Reprod Update 2006; 12: 513-518.